264 related articles for article (PubMed ID: 36771843)
1. Fabrication of Sustained Release Curcumin-Loaded Solid Lipid Nanoparticles (Cur-SLNs) as a Potential Drug Delivery System for the Treatment of Lung Cancer: Optimization of Formulation and In Vitro Biological Evaluation.
Rahman MA; Ali A; Rahamathulla M; Salam S; Hani U; Wahab S; Warsi MH; Yusuf M; Ali A; Mittal V; Harwansh RK
Polymers (Basel); 2023 Jan; 15(3):. PubMed ID: 36771843
[TBL] [Abstract][Full Text] [Related]
2. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
3. Preparation of Curcumin Solid Lipid Nanoparticles Loaded with Flower-Shaped Lactose for Lung Inhalation and Preliminary Evaluation of Cytotoxicity In Vitro.
Li N; Li X; Cheng P; Yang P; Shi P; Kong L; Liu H
Evid Based Complement Alternat Med; 2021; 2021():4828169. PubMed ID: 34745284
[TBL] [Abstract][Full Text] [Related]
4. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
5. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
[TBL] [Abstract][Full Text] [Related]
6. Intracellular Uptake of Curcumin-Loaded Solid Lipid Nanoparticles Exhibit Anti-Inflammatory Activities Superior to Those of Curcumin Through the NF-κB Signaling Pathway.
Wang J; Zhu R; Sun D; Sun X; Geng Z; Liu H; Wang SL
J Biomed Nanotechnol; 2015 Mar; 11(3):403-15. PubMed ID: 26307824
[TBL] [Abstract][Full Text] [Related]
7. Anticancer and Antibacterial Properties of Curcumin-Loaded Mannosylated Solid Lipid Nanoparticles for the Treatment of Lung Diseases.
Chae J; Choi Y; Hong J; Kim N; Kim J; Lee HY; Choi J
ACS Appl Bio Mater; 2024 Apr; 7(4):2175-2185. PubMed ID: 38478917
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and Pharmacodynamics of Curcumin-Loaded Solid Lipid Nanoparticles in the Management of Streptozotocin-Induced Diabetes Mellitus: Application of Central Composite Design.
Sharma JB; Bhatt S; Saini V; Kumar M
Assay Drug Dev Technol; 2021; 19(4):262-279. PubMed ID: 34000202
[No Abstract] [Full Text] [Related]
9. Curcumin-Loaded Solid Lipid Nanoparticles Enhanced Anticancer Efficiency in Breast Cancer.
Wang W; Chen T; Xu H; Ren B; Cheng X; Qi R; Liu H; Wang Y; Yan L; Chen S; Yang Q; Chen C
Molecules; 2018 Jun; 23(7):. PubMed ID: 29966245
[TBL] [Abstract][Full Text] [Related]
10. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of paclitaxel and curcumin loaded solid lipid nanoparticles for improved targeting of lung cancer:
Li M; Fang G; Zahid F; Saleem R; Ishrat G; Ali Z; Naeem M; Din FU
Heliyon; 2024 May; 10(9):e30290. PubMed ID: 38720725
[TBL] [Abstract][Full Text] [Related]
12. Enhanced photocytotoxicity of curcumin delivered by solid lipid nanoparticles.
Jiang S; Zhu R; He X; Wang J; Wang M; Qian Y; Wang S
Int J Nanomedicine; 2017; 12():167-178. PubMed ID: 28053531
[TBL] [Abstract][Full Text] [Related]
13. Sustained release Curcumin loaded Solid Lipid Nanoparticles.
Jourghanian P; Ghaffari S; Ardjmand M; Haghighat S; Mohammadnejad M
Adv Pharm Bull; 2016 Mar; 6(1):17-21. PubMed ID: 27123413
[TBL] [Abstract][Full Text] [Related]
14. Novel Curcumin-Resveratrol Solid Nanoparticles Synergistically Inhibit Proliferation of Melanoma Cells.
Palliyage GH; Hussein N; Mimlitz M; Weeder C; Alnasser MHA; Singh S; Ekpenyong A; Tiwari AK; Chauhan H
Pharm Res; 2021 May; 38(5):851-871. PubMed ID: 33982225
[TBL] [Abstract][Full Text] [Related]
15. Formulation, development and evaluation of hyaluronic acid-conjugated liposomal nanoparticles loaded with regorafenib and curcumin and their in vitro evaluation on colorectal cancer cell lines.
Shnaikat SG; Shakya AK; Bardaweel SK
Saudi Pharm J; 2024 Jul; 32(7):102099. PubMed ID: 38817822
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the hepatoprotective effect of curcumin-loaded solid lipid nanoparticles against paracetamol overdose toxicity
Hussein RM; Kandeil MA; Mohammed NA; Khallaf RA
J Liposome Res; 2022 Dec; 32(4):365-375. PubMed ID: 35132919
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical Characterization, Stability, and In Vitro Evaluation of Curcumin-Loaded Solid Lipid Nanoparticles Prepared Using Biocompatible Synthetic Lipids.
Patra S; Dey J; Chakraborty A
ACS Appl Bio Mater; 2023 Jul; 6(7):2785-2794. PubMed ID: 37403739
[TBL] [Abstract][Full Text] [Related]
18. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.
Das S; Ng WK; Kanaujia P; Kim S; Tan RB
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):483-9. PubMed ID: 21831615
[TBL] [Abstract][Full Text] [Related]
19. Novel Nanostructured Lipid Carriers Co-Loaded with Mesalamine and Curcumin: Formulation, Optimization and In Vitro Evaluation.
Awasthi A; Kumar B; Gulati M; Vishwas S; Corrie L; Kaur J; Khursheed R; Muhammed RA; Kala D; Porwal O; Babu MR; Chaitanya MVNL; Kumar A; Pandey NK; Dureja H; Chellappan DK; Jha NK; Gupta G; Prasher P; Kumar D; Dua K; Singh SK
Pharm Res; 2022 Nov; 39(11):2817-2829. PubMed ID: 36195824
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme.
Wang L; Wang X; Shen L; Alrobaian M; Panda SK; Almasmoum HA; Ghaith MM; Almaimani RA; Ibrahim IAA; Singh T; Baothman AA; Choudhry H; Beg S
Biomed Pharmacother; 2021 Jun; 138():111461. PubMed ID: 33706131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
